New drug development: a regulatory overview
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Waltham, MA
PAREXEL International Corporation
© 2008
|
| Ausgabe: | Eighth Edition |
| Schlagworte: | |
| Beschreibung: | 362 Seiten |
| ISBN: | 1882615859 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV043957719 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 161213s2008 |||| 00||| eng d | ||
| 020 | |a 1882615859 |9 1-882615-85-9 | ||
| 035 | |a (OCoLC)254734692 | ||
| 035 | |a (DE-599)BVBBV043957719 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 | ||
| 084 | |a VR 2500 |0 (DE-625)147655: |2 rvk | ||
| 100 | 1 | |a Mathieu, Mark |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a New drug development |b a regulatory overview |c by Mark Mathieu with contibutions from Christopher-Paul Milne |
| 250 | |a Eighth Edition | ||
| 264 | 1 | |a Waltham, MA |b PAREXEL International Corporation |c © 2008 | |
| 300 | |a 362 Seiten | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Zulassung |0 (DE-588)4127410-6 |2 gnd |9 rswk-swf |
| 651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 0 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | 2 | |a Zulassung |0 (DE-588)4127410-6 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029366424 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804176911822225408 |
|---|---|
| any_adam_object | |
| author | Mathieu, Mark |
| author_facet | Mathieu, Mark |
| author_role | aut |
| author_sort | Mathieu, Mark |
| author_variant | m m mm |
| building | Verbundindex |
| bvnumber | BV043957719 |
| classification_rvk | VR 2500 |
| ctrlnum | (OCoLC)254734692 (DE-599)BVBBV043957719 |
| discipline | Chemie / Pharmazie |
| edition | Eighth Edition |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01275nam a2200373 c 4500</leader><controlfield tag="001">BV043957719</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">161213s2008 |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1882615859</subfield><subfield code="9">1-882615-85-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)254734692</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043957719</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VR 2500</subfield><subfield code="0">(DE-625)147655:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mathieu, Mark</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New drug development</subfield><subfield code="b">a regulatory overview</subfield><subfield code="c">by Mark Mathieu with contibutions from Christopher-Paul Milne</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Eighth Edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Waltham, MA</subfield><subfield code="b">PAREXEL International Corporation</subfield><subfield code="c">© 2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">362 Seiten</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029366424</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| geographic | USA (DE-588)4078704-7 gnd |
| geographic_facet | USA |
| id | DE-604.BV043957719 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:39:43Z |
| institution | BVB |
| isbn | 1882615859 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029366424 |
| oclc_num | 254734692 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | 362 Seiten |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| publisher | PAREXEL International Corporation |
| record_format | marc |
| spelling | Mathieu, Mark Verfasser aut New drug development a regulatory overview by Mark Mathieu with contibutions from Christopher-Paul Milne Eighth Edition Waltham, MA PAREXEL International Corporation © 2008 362 Seiten txt rdacontent n rdamedia nc rdacarrier Arzneimittel (DE-588)4003115-9 gnd rswk-swf Zulassung (DE-588)4127410-6 gnd rswk-swf USA (DE-588)4078704-7 gnd rswk-swf USA (DE-588)4078704-7 g Arzneimittel (DE-588)4003115-9 s Zulassung (DE-588)4127410-6 s 1\p DE-604 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Mathieu, Mark New drug development a regulatory overview Arzneimittel (DE-588)4003115-9 gnd Zulassung (DE-588)4127410-6 gnd |
| subject_GND | (DE-588)4003115-9 (DE-588)4127410-6 (DE-588)4078704-7 |
| title | New drug development a regulatory overview |
| title_auth | New drug development a regulatory overview |
| title_exact_search | New drug development a regulatory overview |
| title_full | New drug development a regulatory overview by Mark Mathieu with contibutions from Christopher-Paul Milne |
| title_fullStr | New drug development a regulatory overview by Mark Mathieu with contibutions from Christopher-Paul Milne |
| title_full_unstemmed | New drug development a regulatory overview by Mark Mathieu with contibutions from Christopher-Paul Milne |
| title_short | New drug development |
| title_sort | new drug development a regulatory overview |
| title_sub | a regulatory overview |
| topic | Arzneimittel (DE-588)4003115-9 gnd Zulassung (DE-588)4127410-6 gnd |
| topic_facet | Arzneimittel Zulassung USA |
| work_keys_str_mv | AT mathieumark newdrugdevelopmentaregulatoryoverview |